<DOC>
	<DOCNO>NCT00261300</DOCNO>
	<brief_summary>Gastroesophageal reflux disease ( GERD ) medical condition affect stomach esophagus . GERD might occur low esophageal sphincter close properly stomach content leak back ( reflux ) esophagus . GERD one common medical disorder , estimate 50 % adult report reflux symptom . One main symptom GERD heartburn . It occur acidic content stomach touch line esophagus , cause burn sensation chest throat . Proton pump inhibitor pantoprazole relieve symptom GERD peptic ulcer large proportion patient . Additionally , long-term treatment proton pump inhibitor may need patient chronic ulcer disease cause H. pylorus ( H. pylori stomach-dwelling bacteria often associated ulcer stomach duodenum ) . The aim study evaluate long-term effect pantoprazole patient chronic gastric acid-related complaint . The study duration consist 5-year treatment period . Pantoprazole administer daily . The study provide data long-term safety , tolerability , efficacy pantoprazole .</brief_summary>
	<brief_title>Long-term Pantoprazole Trial Patients With Symptoms Chronic Acid Peptic Complaints ( BY1023/VMG-708 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main Patients complete ALTANA Pharma study BY1023/FK3006 ( longterm clinical trial regard efficacy tolerability Pantoprazole patient respond treatment H2receptor antagonists omeprazole ) Written informed consent Main Concomitant diseases Pregnant nursing female patient ; female patient childbearing potential use reliable contraception</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Gastric acid</keyword>
	<keyword>GERD</keyword>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>Pantoprazole</keyword>
	<keyword>Proton pump inhibitor</keyword>
</DOC>